EU MDR and IVDR regulatory strategy services for medical devices and IVDs. Gap analysis, roadmap, and NB-ready submissions.
EU MDR & IVDR Regulatory Strategy Services
Bioexcel supports manufacturers with end-to-end EU MDR and IVDR regulatory strategy, ensuring structured planning, evidence alignment, and Notified Body-ready submissions across the product lifecycle.
What We Support
Bioexcel supports manufacturers with end-to-end regulatory strategy across:
- EU MDR (2017/745) & IVDR (2017/746)
- US FDA (510(k), De Novo, PMA, IDE)
- CDSCO (India Medical Device Rules 2017)
- UK MHRA (UKCA)
- TGA (Australia)
- Health Canada
- Other international regulatory jurisdictions
From classification to submission planning, we build structured, regulator-ready pathways that accelerate approvals and reduce review cycles.
Engage Our EU MDR Strategy Team
Integrated Multi-Region Regulatory Strategy
Bioexcel develops regulatory roadmaps aligned with global compliance requirements, ensuring structured planning, technical documentation readiness, and authority-facing submission strategy across the product lifecycle.
We operate at the intersection of regulatory intelligence, clinical evidence integration, and risk-based compliance architecture.
Plan Your Global Regulatory Roadmap
Beyond Documentation. Strategic Regulatory Positioning.
We don't only prepare files. We design regulatory positioning strategies that anticipate:
- Notified Body review behavior
- FDA deficiency trends
- CDSCO query patterns
- Post-market surveillance expectations
- Lifecycle evidence requirements
Our strategy reduces regulatory uncertainty and strengthens approval confidence.
Discuss Your Global Regulatory Strategy
Regulatory Strategy & Execution Capabilities
Strategic Planning:
- Device classification & conformity route determination (EU / US / India / UK / AU / CA)
- Multi-country regulatory pathway mapping
- Regulatory gap assessment & remediation planning
- Technical documentation architecture (STED / EU Technical File / US submissions)
- Clinical & performance evidence integration (CER / PER / PMCF / PMS / RWE)
- Global submission sequencing strategy
Capabilities & Regulatory
Capabilities — Device classification & conformity assessment route – MDR/IVDR gap assessment & remediation roadmap – Evidence strategy (CER/PER/PMCF integration) – NB engagement & submission planning. Regulatory — Alignment EU MDR (2017/745), EU IVDR (2017/746), MDCG guidance.
Regulatory Alignment
We align regulatory strategy with: EU MDR (2017/745), EU IVDR (2017/746), MDCG guidance documents, US FDA (21 CFR Parts 807, 812, 814, 820), CDSCO MDR 2017 & CDSCO guidance, ISO 13485 & ISO 14155, ICH-GCP (where applicable). Our approach ensures regulator-facing defensibility and structured submission readiness.
Frequently Asked Questions (FAQ)
Regulatory
EU MDR & IVDR Regulatory Strategy Services
EU MDR and IVDR regulatory strategy services for medical devices and IVDs. Gap analysis, roadmap, and NB-ready submissions.